Cardinal Capital Management Haemonetics Corp Transaction History
Cardinal Capital Management
- $582 Million
- Q2 2024
A detailed history of Cardinal Capital Management transactions in Haemonetics Corp stock. As of the latest transaction made, Cardinal Capital Management holds 14,832 shares of HAE stock, worth $1.16 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
14,832
Previous 14,283
3.84%
Holding current value
$1.16 Million
Previous $1.22 Million
0.66%
% of portfolio
0.21%
Previous 0.2%
Shares
32 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.2MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$540 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$465 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$401 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$300 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$299 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.01B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...